Call Us: +44 (0) 1752 753723[email protected]

Europe Approves Holoclar®, the First Stem Cell-Based Medicinal Product

The European Commission has granted a conditional marketing authorization, under Regulation (EC) No 726/2004, to Holoclar®, an advanced therapy based on autologous stem cells and capable to restore the eyesight of patients with severe cornea damage. Holoclar® is manufactured by Holostem Terapie Avanzate (Holostem Advanced Therapies) – a spin-off...